- AU$10.02m
- AU$6.62m
- 12
- 61
- 34
- 30
2022 June 30th | 2023 June 30th | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Total Revenue | 0 | 0 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Depreciation and Amortization | ||
Total Operating Expenses | 0.552 | 1.46 |
Operating Profit | -0.552 | -1.46 |
Total Net Non Operating Interest Income / Expense | ||
Other Net Non Operating Costs | ||
Net Income Before Taxes | -0.552 | -1.35 |
Provision for Income Taxes | ||
Net Income After Taxes | -0.552 | -1.35 |
Net Income Before Extraordinary Items | ||
Net Income | -0.552 | -1.35 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -0.552 | -1.35 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.007 | -0.02 |
Dividends per Share |